Angiopoietin-2: A Potential Mediator of the Glycocalyx Injury in Adult Nephrotic Patients
AbstractIntroduction: Glomerulopathy is a group of diseases that affect mainly young adults between the ages of 20 and 40 years. Recently, it has been demonstrated that syndecan-1, a biomarker of endothelial glycocalyx damage, is increased in nephrotic patients with near-normal renal function and it is important to endothelial dysfunction in these patients. Angiopoietin-2 (AGPT2) is an endothelial growth factor that promotes cell derangement. Here we evaluated AGPT2 levels in patients with nephrotic syndrome, near-normal renal function and the possible interaction of AGPT2 with endothelial glycocalyx derangement. Methods: This was a cross-sectional study performed from January through November 2017. Adult patients (age > 18 years) with nephrotic syndrome and without immunosuppression were included. Blood samples were drawn after a 12 h fast for later measurement of syndecan-1 and AGPT2. Mediation analyses were performed to assess the hypothesized associations of nephrotic syndrome features and AGPT2 with syndecan-1. Results: We included 65 patients, 37 (56.9%) of them female, with primary glomerular disease. Syndecan-1 in nephrotic patients was higher than in control individuals (102.8 ± 36.2 vs. 28.2 ± 9.8 ng/mL, p < 0.001). Correlation of syndecan-1 with the main features of nephrotic syndrome after adjustment for age and estmmated glomerular filtration rate (eGFR) demonstrated that syndecan-1 was significantly associated with 24-h urinary protein excretion, total cholesterol, LDL (low density lipoprotein)-cholesterol, HDL (high-density lipoprotein)-cholesterol, and triglycerides. Angiopoietin-2 was independently associated with serum albumin, 24 h urinary protein excretion, total cholesterol, and LDL-cholesterol, in addition to being strongly associated with syndecan-1 (0.461, p < 0.001). The results of the mediation analyses showed that the direct association between LDL-cholesterol and syndecan-1 was no longer significant after AGPT-2 was included in the mediation analysis. AGPT2 explained 56% of the total observed association between LDL-cholesterol and syndecan-1. Conclusion: The association between LDL-cholesterol and glycocalyx derangement in nephrotic patients is possibly mediated by AGPT2. View Full-Text
Share & Cite This Article
Chaves, M.M.S.; Mendes, M.S.; Schwermann, M.P.; Queiroz, R.; Coelho, R.F.; Salmito, F.T.S.; Meneses, G.C.; Martins, A.M.C.; Moreira, A.C.O.M.; Libório, A.B. Angiopoietin-2: A Potential Mediator of the Glycocalyx Injury in Adult Nephrotic Patients. J. Clin. Med. 2018, 7, 401.
Chaves MMS, Mendes MS, Schwermann MP, Queiroz R, Coelho RF, Salmito FTS, Meneses GC, Martins AMC, Moreira ACOM, Libório AB. Angiopoietin-2: A Potential Mediator of the Glycocalyx Injury in Adult Nephrotic Patients. Journal of Clinical Medicine. 2018; 7(11):401.Chicago/Turabian Style
Chaves, Maria M.S.; Mendes, Matheus S.; Schwermann, Maximilian P.; Queiroz, Raquel; Coelho, Regina F.; Salmito, Francisco T.S.; Meneses, Gdayllon C.; Martins, Alice M.C.; Moreira, Ana C.O.M.; Libório, Alexandre B. 2018. "Angiopoietin-2: A Potential Mediator of the Glycocalyx Injury in Adult Nephrotic Patients." J. Clin. Med. 7, no. 11: 401.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.